Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?

Is a controlled trial of long-term oral anticoagulants in patients with stroke and non-rheumatic atrial fibrillation worthwhile?

A controlled randomised trial large enough to assess the value of anticoagulating stroke patients in atrial fibrillation would be difficult to conduct in the UK and the results would be applicable to only a small proportion of stroke patients. It would be more worthwhile to organise a trial that als...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Sandercock, P, Warlow, C, Bamford, J, Peto, R, Starkey, I
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	1986

Míreanna comhchosúla

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
de réir: Turpie AGG
Foilsithe / Cruthaithe: (2014-03-01)

A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation
de réir: Andrei Viktorovich Fonyakin, et al.
Foilsithe / Cruthaithe: (2012-09-01)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
de réir: Paula Tiili, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
de réir: Tommaso Sacquegna, et al.
Foilsithe / Cruthaithe: (2015-12-01)

Prevalence of oral anticoagulation in atrial fibrillation
de réir: Eduardo Bartholomay, et al.
Foilsithe / Cruthaithe: (2014-09-01)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
de réir: Jin-Yi Hsu, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
de réir: Eric Duong, BSc, MSc, PharmD, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Mitral valve repair in rheumatics: Is it still worthwhile?
de réir: Manuel J. Antunes
Foilsithe / Cruthaithe: (2017-04-01)

PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
de réir: V. I. Petrov, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
de réir: Ting-Yung Chang, et al.
Foilsithe / Cruthaithe: (2018-09-01)

Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation
de réir: Jovanović Dejana R.
Foilsithe / Cruthaithe: (2020-01-01)

Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation
de réir: Klaus K. Witte, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
de réir: Suárez Fernández C, et al.
Foilsithe / Cruthaithe: (2018-02-01)

Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation
de réir: Giuseppe Armentaro, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Do all patients with atrial fibrillation need long-term anticoagulation?
de réir: Munish Sharma, et al.
Foilsithe / Cruthaithe: (2017-07-01)

Long‐Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation
de réir: Jaejin An, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Atrial fibrillation, electroconvulsive therapy, stroke risk, and anticoagulation
de réir: Meera Kapadia, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.
de réir: Holt, T, et al.
Foilsithe / Cruthaithe: (2012)

EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION
de réir: S. K. Zyryanov, et al.
Foilsithe / Cruthaithe: (2017-07-01)

Preventing stroke in atrial fibrillation patients &ndash; clinical utility of oral anticoagulants
de réir: Jhawar MB, et al.
Foilsithe / Cruthaithe: (2012-04-01)

Patients' Perceptions of Atrial Fibrillation, Stroke Risk, and Oral Anticoagulation Treatment: An International Survey
de réir: Deirdre A. Lane, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Stroke prevention within primary care: management of atrial fibrillation using oral anticoagulation
de réir: Paulo Andrade Lotufo

Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants
de réir: Gabet A, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
de réir: Amin A
Foilsithe / Cruthaithe: (2013-01-01)

Mood disorders in long-term survivors of stroke: associations with brain lesion location and volume.
de réir: Sharpe, M, et al.
Foilsithe / Cruthaithe: (1990)

Oral anticoagulant therapy for older patients with atrial fibrillation
de réir: Mario Bo, et al.
Foilsithe / Cruthaithe: (2017-09-01)

Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer
de réir: Li-Ying Yu, et al.
Foilsithe / Cruthaithe: (2022-06-01)

The temporal context of oral anticoagulation outcome in atrial fibrillation
de réir: Anke C. Fender, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
de réir: Michela Giustozzi, et al.
Foilsithe / Cruthaithe: (2019-04-01)

Long-term prognostic impact of anticoagulation on patients with atrial fibrillation undergoing hemodialysis
de réir: Ruth María Sánchez Soriano, et al.
Foilsithe / Cruthaithe: (2018-07-01)

Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)
de réir: E. I. Baranova, et al.
Foilsithe / Cruthaithe: (2020-02-01)

Risk of gastrointestinal bleeding in Asian patients receiving oral anticoagulants for stroke prevention in atrial fibrillation
de réir: Alejandro Bimbo Diaz, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Frequency of and factors associated with underdosing of direct oral anticoagulants in patients with ischaemic stroke and atrial fibrillation
de réir: E.M. Bacas, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
de réir: Ki-Woong Nam, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Evaluation of the timing of using direct oral anticoagulants after ischemic stroke for patients with atrial fibrillation
de réir: Hui-Tzu Yu, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
de réir: Alfredo Caturano, et al.
Foilsithe / Cruthaithe: (2019-09-01)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
de réir: Celina M. Yong, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation
de réir: Toshitaka Umemura, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
de réir: Xiaoxi Yao, et al.
Foilsithe / Cruthaithe: (2016-02-01)

Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation.
de réir: Toshitaka Umemura, et al.
Foilsithe / Cruthaithe: (2020-01-01)